GILD: 吉利德科学

GILD新闻

• 12:56 Gilead Sciences' Quarterly Earnings Preview: What You Need to Know
• 12:53 Should You Buy, Sell or Hold J&J's Stock Post a Robust Q2 Performance?
• 22:00 Gilead Sciences (GILD) Sees a More Significant Dip Than Broader Market: Some Facts to Know
• 16:50 Gilead Leads The Battle Vs. HIV. But Rivals Are On The Move.
• 13:00 Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know
• 00:19 US Q2 earnings outlook: sector rotation and Mag7 valuation reset
• 22:00 Gilead Sciences (GILD) Stock Dips While Market Gains: Key Facts
• 20:01 S&P 500 Top Stock Gainers Today, 7/10/26 - TipRanks.com
• 18:46 A New Look At Legend Biotech: Plenty Of Upside For Carvykti (NASDAQ:LEGN)
• 14:28 SBIO: Biotech Breakthrough Opportunities Screened For Cash Burn (NYSEARCA:SBIO)
• 18:36 Will the Label Expansion of Trodelvy Strengthen GILD's Oncology Portfolio?
• 18:05 What's Going on With Gilead Sciences Stock Monday? - Gilead Sciences (NASDAQ:GILD)
• 13:00 Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It
• 17:06 KYMR Stock Soars 51% YTD on Progress of Atopic Dermatitis Drug
• 13:03 Vertex Pharmaceuticals Has One Of The Widest And Most Durable Moats In Biotech (VRTX)
• 12:22 Gilead (GILD) Moves 3.3% Higher: Will This Strength Last?
• 15:05 Nurix Stock Up 29% in a Month: Here's What You Should Know
• 14:45 Ascendis Pharma (ASND) Moves 9.9% Higher: Will This Strength Last?
• 22:00 Gilead Sciences (GILD) Dips More Than Broader Market: What You Should Know
• 14:19 Gilead's Breast Cancer Drug Trodelvy Wins FDA Nod for Expanded Use
• 15:25 Gilead Wins EC Approval to Expand Trodelvy's Label in Metastatic TNBC
• 13:00 Gilead Sciences: The Market Is Underestimating Its Growth Runway (NASDAQ:GILD)
• 00:20 Dividend Champion, Contender, And Challenger Highlights: Week Of June 21
• 13:00 Investors Heavily Search Gilead Sciences, Inc. (GILD): Here is What You Need to Know